Navigating Cell & Gene Therapy: The Quality Path to a Bright Future
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Navigating Cell & Gene Therapy: The Quality Path to a Bright Future
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Send us a text
In this episode of the Quality Grind Podcast, hosts Joe Toscano and Mike Kent conclude their four-part series on Cell and Gene Therapy with guest Ray Kaczmarek. They discuss the importance of building relationships and implementing solid quality systems across the development lifecycle.
Ray shares his pragmatic views on ensuring quality and compliance from early stages, the significance of robust training programs, and the future prospects of the Cell and Gene Therapy field. Tune in for insightful discussions on maintaining regulatory standards, managing deviations, and fostering a culture of responsibility and innovation in the life sciences industry.
Contact MEDVACON:
- Message us at @MedvaconLifeSciences on LinkedIn
- Visit our website at www.medvacon.com/contact
- Email us at qualitygrind@medvacon.com
Thanks for listening! Don't forget to follow us @medvacon on all platforms for updates on blogs and podcasts!